Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asahi Ito

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Cancer Immunology, Immunotherapy : CII|August 18, 2010
A complement-dependent cytotoxicity-enhancing anti-CD20 antibody mediating potent antitumor activity in the humanized NOD/Shi-scid, IL-2Rγ(null) mouse lymphoma modelFumihiko Sato, Asahi Ito, Takashi Ishida, et al.
British Journal of Haematology|November 18, 2020
Clinical significance of CD28 gene-related activating alterations in adult T-cell leukaemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
The Journal of Pathology. Clinical Research|October 6, 2020
Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphomaKeiichiro Fujii, Yuma Sakamoto, Ayako Masaki, et al.
Cancer Science|November 5, 2021
Clinicopathological significance of CD28 overexpression in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Blood Advances|May 21, 2020
Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphomaMasato Saito, Toshihiko Ishii, Itaru Urakawa, et al.
Frontiers in Oncology|March 6, 2023
Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with <i>KMT2A</i> rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like featuresTomotaka Suzuki, Rui Yokomori, Takaomi Sanda, et al.
Oncogene|August 5, 2020
Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphomaHaruhito Totani, Keiko Shinjo, Miho Suzuki, et al.
Cancer Medicine|July 20, 2024
Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasoneTakuto Tachita, Masaki Ri, Sho Aoki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 9, 2018
[Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance mimicking POEMS syndrome]Takashi Kanamori, Shigeru Kusumoto, Kenji Okita, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|May 15, 2020
Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapyTakaki Kikuchi, Shigeru Kusumoto, Yasuhito Tanaka, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Cancer Immunology, Immunotherapy : CII|August 18, 2010
A complement-dependent cytotoxicity-enhancing anti-CD20 antibody mediating potent antitumor activity in the humanized NOD/Shi-scid, IL-2Rγ(null) mouse lymphoma modelFumihiko Sato, Asahi Ito, Takashi Ishida, et al.
British Journal of Haematology|November 18, 2020
Clinical significance of CD28 gene-related activating alterations in adult T-cell leukaemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
The Journal of Pathology. Clinical Research|October 6, 2020
Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphomaKeiichiro Fujii, Yuma Sakamoto, Ayako Masaki, et al.
Cancer Science|November 5, 2021
Clinicopathological significance of CD28 overexpression in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Blood Advances|May 21, 2020
Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphomaMasato Saito, Toshihiko Ishii, Itaru Urakawa, et al.
Frontiers in Oncology|March 6, 2023
Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with <i>KMT2A</i> rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like featuresTomotaka Suzuki, Rui Yokomori, Takaomi Sanda, et al.
Oncogene|August 5, 2020
Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphomaHaruhito Totani, Keiko Shinjo, Miho Suzuki, et al.
Cancer Medicine|July 20, 2024
Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasoneTakuto Tachita, Masaki Ri, Sho Aoki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 9, 2018
[Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance mimicking POEMS syndrome]Takashi Kanamori, Shigeru Kusumoto, Kenji Okita, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|May 15, 2020
Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapyTakaki Kikuchi, Shigeru Kusumoto, Yasuhito Tanaka, et al.
Pageof 7